2026 SCAI SHOCK

Evidence for Use of Cangrelor in Cardiogenic Shock from Observational Data: Where are we in 2026?

Jennifer A Rymer, MD, MBA, MHS, Duke University Hospital, Chapel Hill, NC
Jennifer A Rymer, MD, MBA, MHS, Duke University Hospital, Chapel Hill, NC

View Recording Download Slides
See more of: Lunch Program: Optimizing Antiplatelet Therapy in Cardiogenic Shock
See more of: SCAI SHOCK: Home of the Shock Team
<< Previous Presentation | Next Presentation